Neuroprotective strategies in epilepsy

Advances in Experimental Medicine and Biology

Volumn 497, Issue , 2002, Pages 209-224

  Carlen, Peter L ^a   Pelletier, Marc R ^a   Ouanounou, Aviv ^a   Tymianski, Michael ^a   Zhang, Liang ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ANTIOXIDANT; BICUCULLINE; CALCIUM; CALRETININ; CORTICOSTEROID; CYTOKINE; FREE RADICAL; FUROSEMIDE; GLUTAMIC ACID; KAINIC ACID; LIDOCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTROPHIN; PHENYTOIN; SIPATRIGINE; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN;

APOPTOSIS; AUTOIMMUNE DISEASE; BRAIN INJURY; ELECTROSTIMULATION; EPILEPSY; GAP JUNCTION; HUMAN; HYPOXIA; KINDLING; NERVE CELL; NERVE CELL NECROSIS; NERVE CELL STIMULATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OSMOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN; EPILEPSY; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 0036090785     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (197)

1. Immunological aspects of epilepsy
2. Glutathione levels in specific brain regions of genetically epileptic (tg/tg) mice
3. 2+ signal transduction
4. Convulsive status epilepticus in infants and children: A study of 239 cases
5. Kainic acid-induced seizures: A developmental study
6. Seizure and acute osmotic change: Clinical and neurophysiological aspects
7. Plasmapheresis in Rasmussen's encephalitis
8. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells
9. High dose gamma-globulin for intractable childhood epilepsy
10. Temporal lobe volumetric cell densities in temporal lobe epilepsy
11. Pathologic substrates of epilepsy
12. Trk family of neurotrophin receptors
13. Dormancy of inhibitory interneurons in a model of temporal lobe epilepsy
14. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
15. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures
16. 2+ accumulation
17. Calcium transport and buffering in neurons
18. Convulsive disorders: Status epilepticus
19. Epileptic brain damage. The role of systemic factors that modify cerebral energy metabolism
20. Comparison of phenytoin with non-competitive N-methyl-D-aspartate antagonists in model of focal brain ischemia in rat
21. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar purkinje cells
22. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration
23. Metabotropic glutamate receptor activation decreases epileptiform activity in rat neocortex
24. Electric coupling in epileptogenesis
25. Neuronal loss induced in limbic pathways by kindling: Evidence for induction of hippocampal sclerosis by repeated brief seizures
26. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity
27. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage
28. Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures
29. Regulation of N-methyl-D-aspartate-induced toxicity in the neostriatum: A role for metabotropic glutamate receptors?
30. Pharmacology and physiology of metabotropic glutamate receptors in mammalian central nervous system
31. Coupling between neurons of the developing rat neocortex
32. Epilepsy and neuron loss in the hippocampus
33. Petit Mal: Immunologische aspekte in atiopathogenese und therapie
34. Selective changes in the microorganization of the human epileptogenic neocortex revealed by parvalbumin immunoreactivity
35. Gap junctions in the brain: Where, what type, how many and why?
36. Metabotropic glutamate receptor-induced disinhibition is mediated by reduced transmission at excitatory synapses onto interneurons and inhibitory synapses onto pyramidal cells
37. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes
38. Osmolality-induced changes in extracellular volume alter epileptiform bursts independent of chemical synapses in the rat: Importance of non-synaptic mechanisms in hippocampal epileptogenesis
39. Excitation and inhibition in epilepsy
40. Cholinergic sprouting in the hippocampus: A proposed role for IL-I
41. Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci
42. Animal models of the epilepsies
43. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA deficient patients with epilepsy
44. Induction of cell death by endogenous nerve growth factor through its p75 receptor
45. Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors
46. 2+ release from intracellular stores in cultured cerebral cortical neurons
47. Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons
48. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia
49. Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration
50. 2+ of N-methyl-D-aspartate and quisqualate neurotoxicity in young rat hippocampal slices
51. Roles of specific metabotropic receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability
52. The role of mononuclear phagocytes in wound healing after traumatic injury to the adult mammalian brain
53. Microglial mitogens are produced in the developing and injured mammalian brain
54. Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture
55. The impact of microglia-derived cytokines upon gliosis in the CNS
56. A permanent change in brain function resulting from daily electrical stimulation
57. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion
58. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
59. Metabotropic receptor mediated afterdepolarization in neocortical neurons
60. Kindling in developing animals: Expression of severe seizures and enhanced development of bilateral foci
61. 2+ changes during epileptiform discharges in the immature rat neocortex
62. Alterations in the microenvironment during spreading depression associated with epileptiform discharges in the immature neocortex
63. Apoptosis in target organs of hypertension
64. Light chain ratios and concentrations of serum immunoglobulins in children with epilepsy
65. Immunoglobulin G, A and M light chain ration in children
66. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): Effect of high-dose steroids or immunoglobulins in 19 patients
67. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death
68. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
69. Role of neuronal synchronizing mechanisms in the propagation of spreading depression in the in vivo hippocampus
70. Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity
71. Effects of kainic acid on seizure susceptibility in the developing brain
72. Relationship between anti-GA1 antibody and CNS destructions in nervous diseases
73. Mechanisms in the development of limbic status epilepticus and hippocampal neuronal loss: An experimental study in a model of status epilepticus induced by kindling-like electrical stimulation of the deep prepyriform cortex in rats
74. The development of the interictal spike during kindling in the rat
75. Neurotrophin signal transduction by the Trk receptor
76. Loss of inhibition precedes delayed spontaneous seizures in the hippocampus after tetanic electrical stimulation
77. Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition
78. Antiserum to brain gangliosides produces recurrent epileptiform activity
79. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
80. Glutamate impairs neuronal calcium extrusion while reducing sodium gradient
81. Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures
82. Effet des gammaglobulines sur des epelepsies rebelles
83. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat
84. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats
85. The biochemical basis and pathophysiology of status epilepticus
86. Epileptogenic effects of status epilepticus
87. Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates
88. Prolonged increases in neurotrophic activity associated with kainate-induced hippocampal synaptic reorganization
89. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro
90. Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity
91. The physiology of excitatory amino acids in the vertebrate central nervous system
92. Low morbidity and mortality of status epilepticus in children
93. Activation of metabotropic glutamate receptors differentially affects two classes of hippocampal interneurons and potentiates excitatory synaptic transmission
94. Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist
95. The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury
96. A new model of partial status epilepticus based on kindling
97. The intracellular distribution of calcium
98. Metabolic factors during prolonged seizures and their relation to nerve cell death
99. Excitatory amino acid neurotoxicity and neurodegenerative disease
100. Systemic factors and epileptic brain damage: Prolonged seizures in paralyzed artificially ventilated baboons
101. Prolonged epileptic seizures in primates: Ischemic cell damage and its relation to ictal physiological events
102. Role of metabotropic glutamate receptor subtypes in the patterning of epileptiform activities in vitro
103. Tumour necrosis factor alpha, interleukin 1 and related cytokines in brain development: Normal and pathological
104. Calcium, neuronal hyperexcitability and ischemic injury
105. Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker
106. Calcium signalling in neurons
107. 2+ homeostasis
108. Roles of metabotropic glutamate receptors in brain plasticity and pathology
109. Elevated serum levels of tumour necrosis factor reassociated with progressive encephalopathy in children with acquired immunodeficiency syndrome
110. NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling
111. The excitatory amino acid receptors: Their classes, pharmacology and distinct properties in the function of the central nervous system
112. Kainic acid as a tool for the study of temporal lobe epilepsy
113. Molecular diversity of glutamate receptors and implications for brain function
114. 2+-activated mechanisms in cell killing
115. Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae
116. Kainic acid: A powerful neurotoxic analogue of glutamate
117. Selective enhancement of axonal branching of cultured dentate gyrus neurons by neurotrophic factors
118. Anterior transposition of the ulnar nerve: An electrophysiological study
119. Traitement des encephalopathies epileptiques de l'enfant par les gammaglobulines
120. Selective protection of neuropeptide containing dentate hilar interneurons by non-NMDA receptor blockade in an animal model of status epilepticus
121. Calcium influx and its control by calcium release
122. Changes in calcium currents during ethanol withdrawal in a genetic mouse model
123. Modulation of gap junctional mechanisms during calcium-free induced field burst activity: A possible role for electrotonin coupling in epileptogenesis
124. In vitro hypoxia induces expression of the NR2C subunit of the NMDA receptor in rat cortex and hippocampus
125. The metabotropic glutamate receptors: Structure and functions
126. Brain maturity and selective glutamate receptor subtype activation influence excitotoxic neuronal death morphology along an apoptosis-necrosis continuum
127. Apoptotic and necrotic cell death following kindling induced seizures
128. The role of the piriform cortex in the generation of interictal spikes in the kindled preparation
129. Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones
130. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons
131. A nerve growth factor peptide retards seizure development and inhibits neuronal sprouting in a rat model of epilepsy
132. Lidocaine accelerates neuroelectrical recovery after incomplete global ischemia in rabbits
133. Epileptogenic agents enhance transmission at an identified weak electrical synapse in aplysia
134. Excitatory amino acid metabotropic receptor subtypes and calcium regulation
135. Cell death, gliosis, and synaptic remodelling in the hippocampus of epileptic rats
136. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis
137. Osmolality and nonsynaptic epileptiform bursts in rat CA1 and dentate gyrus
138. Glutamate and the pathophysiology of hypoxic-ischemic brain damage
139. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage
140. Regional increases in brain-derived neurotrophic factor and nerve growth factor mRNAs during amygdaloid kindling, but not in acidic and basist growth factor mRNAs
141. Kindling: Basic mechanisms and clinical validity
142. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation
143. New aspects in the pharmacology of kindling implications for mechanism of action in kindling
144. Relevance of kindling and related processes to human epileptogenesis
145. The biochemical pharmacology of metabotropic glutamate receptors
146. Metabotropic glutamate receptors in brain function and pathology
147. Epileptogenesis in the immature central nervous system
148. Metabotropic glutamate receptor agonists reduce epileptiform activity in the rat neocortex
149. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat
150. Basis for the application of calcium antagonists in neurology: Calcium in the brain under physiological and pathological conditions
151. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis
152. Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity
153. 3-induced epileptogenic foci in the rat brain
154. "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies
155. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy
156. Calcium-binding protein (Calbindin-D28K) and parvalbumin immunocytochemistry: Localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity
157. Permanently altered hippocampal structure, excitability and inhibition after experimental status epilepticus in the rat: The "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy
158. Sustained electrical stimulation of the perforant path duplicates kainate-induced electrophysiological effects and hippocampal damage in rats
159. X-linked dominant Charcot-Marie-Tooth disease and other potential gap-junction diseases of the nervous system
160. Erkrankung des ammonshorns als aetiologisches moment der epilepsien
161. Diphenylhydantoin protects against hypoxia-induced impairment of hippocampal synaptic transmission
162. Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy
163. Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators
164. 2+ exchanger
165. Mossy fiber synaptic reorganization in the epileptic human temporal lobe
166. Synaptic reorganization in the hippocampus induced by abnormal functional activity
167. Phenytoin protects against ischemia-produced neuronal cell death
168. A family of metabotropic glutamate receptors
169. Signal transduction, pharmacological properties, and expression patterns of two metabotropic glutamate receptors, mGluR3 and mGluR4
170. Effects of a metabotropic glutamate agonist, trans-ACPD, on cortical epileptiform activity
171. Electrophysiology of GABA-mediated synaptic transmission and possible roles in epilepsy
172. The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: Protection by early tetrodotoxin or delayed MK-801
173. + channels as targets for neuroprotective drugs
174. Excitatory amino acids in health and disease
175. Apoptosis in the pathogenesis and treatment of disease
176. Intracerebral 1S,3R-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists
177. Role of extracellular space in hyperosmotic suppression of potassium-induced electrographic seizures
178. 2+ injection
179. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site
180. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo
181. Coupling potential in CA1 neurons during calcium-free-induced field burst activity
182. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats
183. Evidence for metabotropic excitatory amino acid receptor heterogeneity: Developmental and brain regional studies
184. A model of status epilepticus based on electrical stimulation of hippocampal afferent pathways
185. Stimulation-induced status epilepticus: Role of hippocampal mossy fibers in the seizures and associated neuropathology
186. Systemic effects of generalized convulsive status epilepticus
187. Pathophysiological mechanisms of brain damage from status epilepticus
188. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists
189. Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials
190. Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro
191. Life, death, and the pursuit of apoptosis
192. Dendritic alterations in rat isocortex within an iron-induced chronic epileptic focus
193. 3 injection into rat isocortex
194. Antiperoxidant pretreatment and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies
195. Effect of phenytoin and corticosteroids on seizures and lipid peroxidation in experimental posttraumatic epilepsy
196. The possible involvement of tetrodotoxin-sensitive ion channels in ischemic neuronal damage in the rat hippocampus
197. The Caenorhabditis elegans genes ced-3 and ced-4 act autonomously to cause programmed cell death